Login to Your Account



From TVs to Biologics

Samsung Dives into Biosimilars With $300M Biogen Idec JV

By Catherine Shaffer
BioWorld Today Contributing Writer

Wednesday, December 7, 2011
Samsung, a noted manufacturer of televisions and other electronic devices, entered the world of biotechnology with its new division, Samsung Biologics, in May. Wasting no time, that company has launched a $300 million joint venture with Biogen Idec Inc. to develop and manufacture biosimilars.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription